Salud financiera de hoja de balance de Bioalpha Holdings Berhad

Salud financiera controles de criterios 5/6

Bioalpha Holdings Berhad tiene un patrimonio de los accionistas total de MYR133.7M y una deuda total de MYR6.1M, lo que sitúa su ratio deuda-patrimonio en 4.6%. Sus activos y pasivos totales son MYR171.0M y MYR37.3M respectivamente.

Información clave

4.6%

Ratio deuda-patrimonio

RM6.10m

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	RM16.08m
Patrimonio	RM133.69m
Total pasivo	RM37.33m
Activos totales	RM171.02m

Actualizaciones recientes sobre salud financiera

Recent updates

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?

Mar 19

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Oct 04

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?

Jun 20

Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely

Mar 01

Why Bioalpha Holdings Berhad (KLSE:BIOHLDG) Could Be Worth Watching

Mar 29

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Mar 03

Can You Imagine How Bioalpha Holdings Berhad's (KLSE:BIOHLDG) Shareholders Feel About The 42% Share Price Increase?

Jan 20

How Much Is Bioalpha Holdings Berhad's (KLSE:BIOHLDG) CEO Getting Paid?

Nov 28

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (MYR38.8M) de BIOHLDG superan a sus pasivos a corto plazo (MYR25.6M).

Pasivo a largo plazo: Los activos a corto plazo de BIOHLDG (MYR38.8M) superan a sus pasivos a largo plazo (MYR11.7M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: BIOHLDG tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de BIOHLDG ha crecido de 3.5% a 4.6% en los últimos 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: Aunque no es rentable BIOHLDG tiene suficiente cash runway para más de 3 años si mantiene su actual nivel positivo de flujo de caja libre.

Pronóstico de cash runway: BIOHLDG no es rentable pero tiene suficiente cash runway para más de 3 años, debido a que el flujo de caja libre es positivo y crece un 2.4% al año.

Salud financiera de hoja de balance de Bioalpha Holdings Berhad

Salud financiera controles de criterios 5/6

Información clave

Actualizaciones recientes sobre salud financiera

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?

Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Recent updates

Bioalpha Holdings Berhad Announces Resignation of Datuk Chong Loong Men as Executive Director

Bioalpha Holdings Berhad, Annual General Meeting, Jun 07, 2024

Full year 2023 earnings released: RM0.028 loss per share (vs RM0.038 loss in FY 2022)

New major risk - Share price stability

Third quarter 2023 earnings released: RM0.002 loss per share (vs RM0.005 loss in 3Q 2022)

New minor risk - Shareholder dilution

Bioalpha Holdings Berhad Appoints Tan Su Ning, Age 31, as Member of Risk Committee Directorate Independent and Non Executive, Date of Change 04 September 2023

Second quarter 2023 earnings released: RM0.003 loss per share (vs RM0.006 loss in 2Q 2022)

Less than half of directors are independent

Bioalpha Holdings Berhad Announces the Retirement of Encik Mohd Nasir Bin Abdullah as Independent and Non Executive Member of Remuneration Committee

First quarter 2023 earnings released: RM0.014 loss per share (vs RM0.003 loss in 1Q 2022)

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?

Full year 2022 earnings released: RM0.036 loss per share (vs RM0.001 loss in FY 2021)

Third quarter 2022 earnings released: RM0.005 loss per share (vs RM0.001 profit in 3Q 2021)

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Second quarter 2022 earnings released: RM0.006 loss per share (vs RM0.001 profit in 2Q 2021)

Bioalpha Holdings Berhad Announces Cessation of Office of Dato' Norhalim Bin Yunus as Non Independent and Non Executive Member of Remuneration Committee

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?

Bioalpha Holdings Berhad Announces Cessation of Tan Sri Dato' Dr. Jalaludin Bin Syed Salim as Independent and Non Executive Chairman of Nomination Committee

First quarter 2022 earnings: EPS and revenues miss analyst expectations

JOE Holding (M) Investment Limited acquired a 12.40% stake in Bioalpha Holdings Berhad (KLSE : BIOHLDG) for MYR 45 million.

Bioalpha Holdings Berhad, Annual General Meeting, Jun 28, 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely

Third quarter 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2021 earnings released

First quarter 2021 earnings released: EPS RM0.001 (vs RM0.006 loss in 1Q 2020)

Why Bioalpha Holdings Berhad (KLSE:BIOHLDG) Could Be Worth Watching

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Earnings beat expectations, revenue disappoints

Full year 2020 earnings released: RM0.037 loss per share (vs RM0.01 profit in FY 2019)

New 90-day low: RM0.25

Can You Imagine How Bioalpha Holdings Berhad's (KLSE:BIOHLDG) Shareholders Feel About The 42% Share Price Increase?

How Much Is Bioalpha Holdings Berhad's (KLSE:BIOHLDG) CEO Getting Paid?

New 90-day high: RM0.32

Bioalpha Holdings Berhad Provides Financial Guidance for the Year Ending December 31, 2020

First half earnings released

New 90-day high - RM0.31

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Análisis de cash runway

Descubre empresas con salud financiera